FilingFirehose · custom report
SEC filings analysis · 7 filings reviewed (last 12 months) · generated 2026-06-11 23:29 UTC
JPMorgan Chase filed seven 8-K forms over the past 12 months, primarily reporting routine corporate governance and debt-related events. The most significant filings include amendments to bylaws and material contracts (Item 3.03, 5.03), acquisitions or asset sales (Item 2.02), regulation changes (Item 5.07), and exhibits/financial statements (Item 9.01). No material activist campaigns, major dilutive equity issuances, or extraordinary financing activity were disclosed in the filings reviewed. The company appears to be operating under normal operational and governance parameters without evidence of financial distress or shareholder-hostile transactions.
No evidence of dilutive equity issuances, stock buyback suspensions, or warrant/option exercises detected in the 8-K filings. The filings reference debt instruments and contract amendments but do not indicate material share count expansion or equity-based compensation acceleration.
| 2026-05-07 8-K | Material Amendment to Bylaws, Material Contracts, and Regulation Changes Reported · filing JPMorgan Chase disclosed amendments to its bylaws (Item 3.03) and material contracts (Item 5.03), along with regulatory or governance changes. This suggests procedural updates to corporate governance or contract terms; without access to full exhibit text, the materiality to investors cannot be fully assessed, but routine bylaw amendments typically reflect operational adjustments. |
| 2026-04-24 8-K | Material Contracts Amendment Filed · filing Item 5.03 filing indicates a material contract amendment. The narrow disclosure scope suggests this was a scheduled or routine update to an existing facility or service agreement. No extraordinary financial impact disclosed. |
| 2026-04-14 8-K | Asset Sale or Acquisition and Financial Statements/Exhibits Disclosure · filing Items 2.02 and 9.01 indicate JPMorgan Chase completed a transaction (acquisition or asset sale) and filed supporting financial statements. The filing does not specify transaction value or strategic significance; investors should review the full exhibit text to assess impact on earnings or business mix. |
| 2026-04-14 8-K | Regulation or Bankruptcy Event Filed with Supporting Documents · filing Items 7.01 and 9.01 suggest JPMorgan Chase disclosed a material regulatory event or restructuring-related item. The vague item coding (7.01 is catch-all) prevents precise interpretation without exhibit access; this warrants review of the full 8-K document. |
| 2026-06-02 8-K | Other Events and Financial Statements Filed · filing Item 8.01 (Other Events) combined with exhibits (9.01) suggests JPMorgan Chase disclosed a non-standard corporate event. Without exhibit content, the nature and investor relevance cannot be assessed; common Item 8.01 disclosures include press releases or regulatory notices. |
| 2026-05-27 8-K | Other Events and Supporting Exhibits Disclosed · filing Similar to the June 2 filing, Item 8.01 with exhibits indicates a non-material-event disclosure. Likely operational, press-release, or informational in nature rather than earnings-impacting. |
| 2026-05-21 8-K | Costs Associated with Exit or Disposal Activities Disclosed; Discrepancy in Item 9.01 Detected · filing Item 5.07 indicates JPMorgan Chase incurred costs related to exit or disposal activities (facility closures, business unit wind-down, etc.). The filer reported only Item 5.07, but analysis detected Item 9.01, suggesting buried or unlisted exhibits. This discrepancy warrants manual review of the actual filing to determine scope of restructuring. |
No active ATM shelf offerings, secondary equity issuances, or major debt financings detected in the 8-K filings reviewed. The filings indicate amendments to existing material contracts (Item 5.03) and regulatory disclosures, but no new capital raise activity. JPMorgan Chase does not appear to be actively tapping debt or equity capital markets based on these 8-K filings.
JPMorgan Chase's 8-K filings over the past 12 months reveal routine corporate governance updates, contract amendments, and minor operational adjustments with no evidence of financial distress, dilutive equity issuance, or activist pressure. The May 21 exit/disposal cost disclosure warrants follow-up investigation to assess the magnitude and earnings impact of any business wind-downs. Investors should monitor upcoming 10-Q and 10-K filings for quantification of restructuring charges and any material changes to revenue guidance or capital deployment plans.
Get the same depth on any US-listed ticker. Delivered to your inbox in 5 minutes.
Want a cheaper gut-check? $9 Mini-Report → · Other samples →